Gainers

• Calidi Biotherapeutics (AMEX:CLDI) stock increased by 166.3% to $0.89 during Wednesday's pre-market session. The company's market cap stands at $10.6 million.
• Basel Medical Group (NASDAQ:BMGL) shares rose 91.75% to $3.49. The market value of their outstanding shares is at $34.1 million.
• Kazia Therapeutics (NASDAQ:KZIA) shares rose 60.87% to $10.98. The market value of their outstanding shares is at $38.1 million.
• ProKidney (NASDAQ:PROK) stock rose 60.35% to $5.98. The company's market cap stands at $483.1 million.
• Mustang Bio (NASDAQ:MBIO) shares increased by 33.45% to $3.55. The company's market cap stands at $11.6 million.
• Verona Pharma (NASDAQ:VRNA) stock rose 20.78% to $104.91. The market value of their outstanding shares is at $7.3 billion.

Losers

• RxSight (NASDAQ:RXST) stock decreased by 42.2% to $7.39 during Wednesday's pre-market session. The market value of their outstanding shares is at $519.7 million.
• ZyVersa Therapeutics (NASDAQ:ZVSA) shares fell 10.84% to $0.69. The market value of their outstanding shares is at $3.6 million.
• Rallybio (NASDAQ:RLYB) shares decreased by 9.94% to $0.46. The market value of their outstanding shares is at $21.2 million.
• Windtree Therapeutics (NASDAQ:WINT) stock fell 9.23% to $0.71. The company's market cap stands at $2.8 million.
• LakeShore Biopharma (NASDAQ:LSB) shares fell 8.72% to $1.26. The market value of their outstanding shares is at $26.3 million.
• Apollomics (NASDAQ:APLM) shares decreased by 6.73% to $6.1. The company's market cap stands at $7.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.